Ascopiave S.p.A.
ASCOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.4% | 10.5% | 21.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 95.1% | 94.3% | 93.5% | 77.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 55.5% | 55.8% | 54.4% | 66.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.5% | 20% | 20% | 33.6% |
| EPS Diluted | 0.17 | 0.17 | 0.15 | 0.21 |
| % Growth | 0% | 13.3% | -28.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |